You are currently viewing Debiut



European Bifurcation Club 2010, EBC 2010 – Budapest, Hungary

Hot topics

Drug Eluting Balloon in Bifurcations Trial : DEBIUT

AuthorPierfrancesco Agostoni MD, PhD, University Medical Centre Utrecht, The Netherlands



To assess the safety and efficacy of the DIORTM Paclitaxel Drug-Eluting Balloon in coronary bifurcations in combination with a BMS, with a specific focus on the side branch (SB) using the provisional T-stenting technique with final kissing balloons.


  1. The use of DEB in bifurcation PCI is feasible
  2. The pre-defined primary endpoint of 50% reduction in MB late loss has not been reached (due to better than expected BMS “angiographic” performance)
  3. There is a strong trend showing a favorable outcome combining DEB with a BMS in MB and using a DEB in SB with regards to overall bifurcation binary restenosis rate
  4. Concerning clinical endpoints, there is a consensual trend favoring DEB+BMS in terms of TLR and total MACE rates compared to BMS +POBA
  5. The use of DEB+BMS in bifurcations with only 3 months of DAPT seems safe with 0% occurrence of stent thrombosis
  6. The non-powered randomised comparison between all three arms shows a clear unfavorable outcome for the use of BMS+POBA in bifurcations


Download here

Leave a Reply